167 related articles for article (PubMed ID: 28610472)
1. Incidental breast carcinoma in reduction mammoplasty.
Huysmans M; Bronckaers M; Schillebeeckx C; Servaes D
Acta Chir Belg; 2017 Oct; 117(5):308-311. PubMed ID: 28610472
[TBL] [Abstract][Full Text] [Related]
2. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers.
Desouki MM; Li Z; Hameed O; Fadare O; Zhao C
Hum Pathol; 2013 Sep; 44(9):1877-81. PubMed ID: 23656973
[TBL] [Abstract][Full Text] [Related]
3. Should we be analysing breast reduction specimens? A systematic analysis of over 1,000 consecutive cases.
Hassan FE; Pacifico MD
Aesthetic Plast Surg; 2012 Oct; 36(5):1105-13. PubMed ID: 22678135
[TBL] [Abstract][Full Text] [Related]
4. Discussion of preoperative mammography in women undergoing reduction mammaplasty.
Klement KA; Hijjawi JB; Neuner J; Kelley K; Kong AL
Breast J; 2019 May; 25(3):439-443. PubMed ID: 30924231
[TBL] [Abstract][Full Text] [Related]
5. A Risk-Stratified Comparison of High-Risk Findings in Reduction Mammoplasty.
Dreifuss SE; Landfair AS; De La Cruz C
Ann Plast Surg; 2018 Jul; 81(1):36-38. PubMed ID: 29762441
[TBL] [Abstract][Full Text] [Related]
6. Incidence of occult contralateral carcinomas of the breast following mastoplasty aimed at symmetrization.
Sorin T; Fyad JP; Pujo J; Colson T; Bordes V; Leroux A; Marchal F; Brix M; Simon E; Verhaeghe JL; Classe JM; Dolivet G
Ann Chir Plast Esthet; 2014 Apr; 59(2):e21-8. PubMed ID: 24530086
[TBL] [Abstract][Full Text] [Related]
7. Should we routinely analyze reduction mammaplasty specimens?
Merkkola-von Schantz PA; Jahkola TA; Krogerus LA; Hukkinen KS; Kauhanen SM
J Plast Reconstr Aesthet Surg; 2017 Feb; 70(2):196-202. PubMed ID: 27908767
[TBL] [Abstract][Full Text] [Related]
8. Incidental atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer.
Li Z; Fadare O; Hameed O; Zhao C; Desouki MM
Hum Pathol; 2014 Jan; 45(1):104-9. PubMed ID: 24182561
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for Pathologic Evaluation of Reduction Mammoplasty Specimens: A Prospective Study With Systematic Tissue Sampling.
Ambaye AB; Goodwin AJ; MacLennan SE; Naud S; Weaver DL
Arch Pathol Lab Med; 2017 Nov; 141(11):1523-1528. PubMed ID: 28795842
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women.
Vande Walle K; Yang DY; Stankowski-Drengler TJ; Livingston-Rosanoff D; Fernandes-Taylor S; Schumacher JR; Wilke LG; Greenberg CC; Neuman HB
Ann Surg Oncol; 2019 Dec; 26(13):4310-4316. PubMed ID: 31538286
[TBL] [Abstract][Full Text] [Related]
11. Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience.
Colwell AS; Kukreja J; Breuing KH; Lester S; Orgill DP
Plast Reconstr Surg; 2004 Jun; 113(7):1984-8. PubMed ID: 15253187
[TBL] [Abstract][Full Text] [Related]
12. Frequency of clinically occult intraepithelial and invasive neoplasia in reduction mammoplasty specimens: a study of 516 cases.
Dotto J; Kluk M; Geramizadeh B; Tavassoli FA
Int J Surg Pathol; 2008 Jan; 16(1):25-30. PubMed ID: 18203780
[TBL] [Abstract][Full Text] [Related]
13. Rate of Incidental Pathological Lesions ın Reduction Mammoplasty Specimens and Incidence of Invasive Breast Carcinoma Following Breast Reduction Operation.
Nergiz D; Süren D; Alikanoğlu AS; Yıldırım HT; Altun ZA; Uslu A
Aesthetic Plast Surg; 2022 Feb; 46(1):83-90. PubMed ID: 34476567
[TBL] [Abstract][Full Text] [Related]
14. The importance of preoperative imaging methods in reduction mammoplasty.
Derebaşınlıoğlu H; Karaca SN
J Plast Reconstr Aesthet Surg; 2022 Apr; 75(4):1424-1430. PubMed ID: 34949572
[TBL] [Abstract][Full Text] [Related]
15. Reduction mammaplasty specimens and occult breast carcinomas.
Kakagia D; Fragia K; Grekou A; Tsoutsos D
Eur J Surg Oncol; 2005 Feb; 31(1):19-21. PubMed ID: 15642421
[TBL] [Abstract][Full Text] [Related]
16. Occult breast cancer during reduction mammoplasty: case report.
Panizzo N; D'Aloja C; Scomersi S; Papa G; Bortul M; Arnez ZM
Ann Ital Chir; 2013 Feb; 84(ePub):. PubMed ID: 23474433
[TBL] [Abstract][Full Text] [Related]
17. The Management of Breast Cancer Detected by Reduction Mammaplasty.
Carlson GW
Clin Plast Surg; 2016 Apr; 43(2):341-7. PubMed ID: 27012792
[TBL] [Abstract][Full Text] [Related]
18. The Incidence of Occult Malignant and High-Risk Pathologic Findings in Breast Reduction Specimens.
Razavi SA; Hart AM; Betarbet U; Li X; Carlson GW; Losken A
Plast Reconstr Surg; 2021 Oct; 148(4):534e-539e. PubMed ID: 34550926
[TBL] [Abstract][Full Text] [Related]
19. A Comparative Retrospective Analysis of Complications After Oncoplastic Breast Reduction and Breast Reduction for Benign Macromastia: Are These Procedures Equally Safe?
Imahiyerobo TA; Pharmer LA; Swistel AJ; Talmor M
Ann Plast Surg; 2015 Oct; 75(4):370-5. PubMed ID: 24691307
[TBL] [Abstract][Full Text] [Related]
20. Reduction mammaplasty in patients with history of breast cancer: The incidence of occult cancer and high-risk lesions.
Merkkola-von Schantz PA; Jahkola TA; Krogerus LA; Kauhanen SMC
Breast; 2017 Oct; 35():157-161. PubMed ID: 28753473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
